French Pharmaceuticals & Biotech Buy the Dip

ABIVAX Société Anonyme

Market Cap: €10.6b

A clinical-stage biotechnology company, develops therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases.

MedinCell

Market Cap: €999.6m

A clinical-stage and commercial biopharmaceutical licensing company, develops long acting injectables in various therapeutic areas in France.

Cellectis

Market Cap: €196.2m

A clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications.